Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zucman

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2006
Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy: a randomized prospective studyPierre De Truchis, Myriam Kirstetter, Antoine Perier, et al.
Presse Medicale (Paris, France : 1983)|February 26, 2013
[Aging and HIV infection: 4 years follow-up of 149 HIV infected patients older than 60 years in West Paris agglomeration (COREVIH Île-de-France Ouest)]Gabriella Flexor, David Zucman, Huguette Berthé, et al.
Plos One|November 3, 2017
Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC)Christel Protière, Bruno Spire, Marion Mora, et al.
Oncotarget|September 24, 2016
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcomaAsma Beldi-Ferchiou, Marion Lambert, Stéphanie Dogniaux, et al.
The Journal of Infectious Diseases|January 16, 2016
Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective StudyLionel Piroth, Odile Launay, Marie-Louise Michel, et al.
Journal of Hepatology|September 26, 2017
Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patientsMaria Patrizia Carrieri, Camelia Protopopescu, Fabienne Marcellin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2007
Urolithiasis in HIV-positive patients treated with atazanavirCarine Couzigou, Michel Daudon, Jean Luc Meynard, et al.
Plos One|April 9, 2020
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individualsMathieu Chalouni, Javier Rodriguez-Centeno, Assia Samri, et al.
Journal of Clinical Medicine|September 10, 2021
An Immunogenicity Report for the Comparison between Heterologous and Homologous Prime-Boost Schedules with ChAdOx1-S and BNT162b2 VaccinesAlexandre Vallée, Marc Vasse, Laurence Mazaux, et al.
Journal of Viral Hepatitis|August 19, 2020
Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)Marion Mora, Trevor Goodyear, Fabienne Marcellin, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2006
Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy: a randomized prospective studyPierre De Truchis, Myriam Kirstetter, Antoine Perier, et al.
Presse Medicale (Paris, France : 1983)|February 26, 2013
[Aging and HIV infection: 4 years follow-up of 149 HIV infected patients older than 60 years in West Paris agglomeration (COREVIH Île-de-France Ouest)]Gabriella Flexor, David Zucman, Huguette Berthé, et al.
Plos One|November 3, 2017
Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC)Christel Protière, Bruno Spire, Marion Mora, et al.
Oncotarget|September 24, 2016
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcomaAsma Beldi-Ferchiou, Marion Lambert, Stéphanie Dogniaux, et al.
The Journal of Infectious Diseases|January 16, 2016
Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective StudyLionel Piroth, Odile Launay, Marie-Louise Michel, et al.
Journal of Hepatology|September 26, 2017
Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patientsMaria Patrizia Carrieri, Camelia Protopopescu, Fabienne Marcellin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2007
Urolithiasis in HIV-positive patients treated with atazanavirCarine Couzigou, Michel Daudon, Jean Luc Meynard, et al.
Plos One|April 9, 2020
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individualsMathieu Chalouni, Javier Rodriguez-Centeno, Assia Samri, et al.
Journal of Clinical Medicine|September 10, 2021
An Immunogenicity Report for the Comparison between Heterologous and Homologous Prime-Boost Schedules with ChAdOx1-S and BNT162b2 VaccinesAlexandre Vallée, Marc Vasse, Laurence Mazaux, et al.
Journal of Viral Hepatitis|August 19, 2020
Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)Marion Mora, Trevor Goodyear, Fabienne Marcellin, et al.
Pageof 8